Foundation for Taxpayer and Consumer Rights Supports Lee-Halpern Petition
By Jerry Flanagan
| 02. 16. 2005
Robert Klein
Chair
Independent Citizen's Oversight Committee
Mr. Klein,
The eyes of the world are on California. New medical treatments and funding strategies developed in the world's sixth leading economy will become national models. The success or failure of the California experiment could decide the fate of stem cell research for years to come.
We are writing to express our deep concern with the failure of the California Institute for Regenerative Medicine ("CIRM") and Independent Citizen's Oversight Committee ("ICOC") to guarantee an open, democratic decision-making process and disregard of state conflict of interest laws. The Foundation for Taxpayer and Consumer Rights (FTCR) calls on the CIRM and ICOC to support the petition filed by Philip R. Lee, MD, and Charles Halpern, JD.
When voters approved the unprecedented $3 billion in taxpayer-funded bonds to support stem cell research, they did so to provide access to innovative medical technologies for all Californians. However, the public availability of new medical technologies is threatened by a web of conflicts between those responsible for awarding research grants and the biotech and pharmaceutical companies who stand...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
